Literature DB >> 9196220

Comparison of methods for extraction of nucleic acid from hemolytic serum for PCR amplification of hepatitis B virus DNA sequences.

A Klein1, R Barsuk, S Dagan, O Nusbaum, D Shouval, E Galun.   

Abstract

The sensitivity of PCR for the amplification of target nucleic acid sequences in clinical diagnostics may often be reduced due to the presence of inhibitory factors. Hemolytic serum contains a number of PCR inhibitors, one of which is hemin. In this study we have found that conventional methods of DNA extraction were not sufficient for the removal of PCR-inhibitory compounds in hemolytic serum. We have therefore compared the efficiency of several commercial and noncommercial methods of nucleic acid purification from hemolytic serum samples prior to PCR amplification. Separation with the QIAamp HCV kit, dialysis with Millipore filters, and bovine serum albumin absorption were all found to be suitable extraction methods for eliminating inhibitors from hemolytic serum for PCR amplification. Using these methods we were able to detect very low levels of hepatitis B virus DNA in hemolytic serum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9196220      PMCID: PMC229868          DOI: 10.1128/jcm.35.7.1897-1899.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Heat-soaked PCR: an efficient method for DNA amplification with applications to forensic analysis.

Authors:  G Ruano; E M Pagliaro; T R Schwartz; K Lamy; D Messina; R E Gaensslen; H C Lee
Journal:  Biotechniques       Date:  1992-08       Impact factor: 1.993

2.  The effects of plant polysaccharides and buffer additives on PCR.

Authors:  T Demeke; R P Adams
Journal:  Biotechniques       Date:  1992-03       Impact factor: 1.993

3.  Inhibitory effects of urine on the polymerase chain reaction for cytomegalovirus DNA.

Authors:  G Khan; H O Kangro; P J Coates; R B Heath
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

4.  False-negative results by polymerase chain reaction due to contamination by glove powder.

Authors:  J G de Lomas; F J Sunzeri; M P Busch
Journal:  Transfusion       Date:  1992-01       Impact factor: 3.157

5.  PCR based diagnosis in the presence of 8% (v/v) blood.

Authors:  M Panaccio; A Lew
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

6.  Hydroxyquinoline overcomes PCR inhibition by UV-damaged mineral oil.

Authors:  M Gilgen; C Höfelein; J Lüthy; P Hübner
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

7.  A distinctive property of Tth DNA polymerase: enzymatic amplification in the presence of phenol.

Authors:  H L Katcher; I Schwartz
Journal:  Biotechniques       Date:  1994-01       Impact factor: 1.993

8.  Inhibition of PCR-based assay for Bordetella pertussis by using calcium alginate fiber and aluminum shaft components of a nasopharyngeal swab.

Authors:  R M Wadowsky; S Laus; T Libert; S J States; G D Ehrlich
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

9.  Hepatitis C virus viremia in SCID-->BNX mouse chimera.

Authors:  E Galun; T Burakova; M Ketzinel; I Lubin; E Shezen; Y Kahana; A Eid; Y Ilan; A Rivkind; G Pizov
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

10.  Suppression of the inhibitory effect of denatured albumin on the polymerase chain reaction by sodium octanoate: application to routine clinical detection of hepatitis B virus at its infectivity threshold in serum.

Authors:  C Vandenvelde; R Scheen; M Defoor; M Duys; J Dumon; D Van Beers
Journal:  J Virol Methods       Date:  1993-05       Impact factor: 2.014

View more
  15 in total

1.  Purification and characterization of PCR-inhibitory components in blood cells.

Authors:  W A Al-Soud; P Rådström
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 2.  PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids.

Authors:  Yoshimasa Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

3.  Comparison of six commercial DNA extraction kits for recovery of cytomegalovirus DNA from spiked human specimens.

Authors:  G A Fahle; S H Fischer
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

4.  Identification and characterization of immunoglobulin G in blood as a major inhibitor of diagnostic PCR.

Authors:  W A Al-Soud; L J Jönsson; P Râdström
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Hepatitis B virus DNA in blood samples positive for antibodies to core antigen and negative for surface antigen.

Authors:  C Gutiérrez; G León; C L Loureiro; N Uzcátegui; F Liprandi; F H Pujol
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

6.  Direct DNA amplification from crude clinical samples using a PCR enhancer cocktail and novel mutants of Taq.

Authors:  Zhian Zhang; Milko B Kermekchiev; Wayne M Barnes
Journal:  J Mol Diagn       Date:  2010-01-14       Impact factor: 5.568

7.  Capacity of nine thermostable DNA polymerases To mediate DNA amplification in the presence of PCR-inhibiting samples.

Authors:  W Abu Al-Soud; P Râdström
Journal:  Appl Environ Microbiol       Date:  1998-10       Impact factor: 4.792

8.  Evaluation of three extraction methods for molecular detection of Schistosoma mansoni infection in human urine and serum samples.

Authors:  Rania M Sarhan; Hanan H Kamel; Ghada A Saad; Ossama A Ahmed
Journal:  J Parasit Dis       Date:  2013-11-20

9.  Mutants of Taq DNA polymerase resistant to PCR inhibitors allow DNA amplification from whole blood and crude soil samples.

Authors:  Milko B Kermekchiev; Lyubka I Kirilova; Erika E Vail; Wayne M Barnes
Journal:  Nucleic Acids Res       Date:  2009-02-10       Impact factor: 16.971

10.  Evaluation of inhibitor-resistant real-time PCR methods for diagnostics in clinical and environmental samples.

Authors:  Adrienne Trombley Hall; Ashley McKay Zovanyi; Deanna Rose Christensen; Jeffrey William Koehler; Timothy Devins Minogue
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.